{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:19:12Z","timestamp":1783358352813,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Natural Sciences and Engineering Council of Canada"},{"DOI":"10.13039\/100009154","name":"University of Windsor","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009154","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Northern Ontario Heritage Funds Corporation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.exppara.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T15:19:44Z","timestamp":1407943184000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection"],"prefix":"10.1016","volume":"145","author":[{"given":"Dema","family":"Kadri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Crater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Raja","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinart","family":"Ananvoranich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2014.08.008_b0005","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.02641-13","article-title":"Identification of Cryptosporidium parvum active chemical series by repurposing the open access malaria box","volume":"58","author":"Bessoff","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2014.08.008_b0010","first-page":"167","article-title":"Observations on the antileukemic activity of pyridine-2-carboxaldehyde thiosemicarbazone and thiocarbohydrazone","volume":"16","author":"Brockman","year":"1956","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2014.08.008_b0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4997\/JRCPE.2010.216","article-title":"A brief history of malaria chemotherapy","volume":"40","author":"Butler","year":"2010","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"10.1016\/j.exppara.2014.08.008_b0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2014.08.008_b0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/37132","article-title":"A plastid organelle as a drug target in apicomplexan parasites","volume":"390","author":"Fichera","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2014.08.008_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","article-title":"Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents","volume":"79","author":"Foley","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exppara.2014.08.008_b0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1139\/m85-134","article-title":"Evidence that the mechanisms of fungitoxicity of 8-quinolinol and its bischelate with copper(II) are different","volume":"31","author":"Gershon","year":"1985","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.exppara.2014.08.008_b0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejmech.2009.11.017","article-title":"A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells","volume":"45","author":"Hu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2014.08.008_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.exppara.2014.08.008_b0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijpara.2011.01.001","article-title":"Construction of a genetic map for Theileria parva: identification of hotspots of recombination","volume":"41","author":"Katzer","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2014.08.008_b0055","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1128\/AAC.00903-08","article-title":"Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs","volume":"52","author":"Krivogorsky","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2014.08.008_b0060","series-title":"Handbook of Biological Statistics","first-page":"115","author":"McDonald","year":"2008"},{"key":"10.1016\/j.exppara.2014.08.008_b0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.41.9.1849","article-title":"Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro","volume":"41","author":"McFadden","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2014.08.008_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality","volume":"41","author":"Meunier","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.exppara.2014.08.008_b0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.clp.2005.04.011","article-title":"Diagnosis and management of toxoplasmosis","volume":"32","author":"Montoya","year":"2005","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.exppara.2014.08.008_b9000","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.exppara.2014.08.008_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.04.029","article-title":"Discovery of a new antileishmanial hit in 8-nitroquinoline series","volume":"54","author":"Paloque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2014.08.008_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","article-title":"Safety and toxicity of sulfadoxine\/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment","volume":"30","author":"Peters","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.exppara.2014.08.008_b0090","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.exppara.2014.08.008_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0026-895X(25)15049-9","article-title":"Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring","volume":"22","author":"Scheibel","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.exppara.2014.08.008_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-1119(95)00786-5","article-title":"Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii","volume":"169","author":"Seeber","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.exppara.2014.08.008_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mib.2013.07.003","article-title":"The metabolic roles of the endosymbiotic organelles of Toxoplasma and Plasmodium spp.","volume":"16","author":"Sheiner","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.exppara.2014.08.008_b0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0024-3205(98)00623-7","article-title":"A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline","volume":"64","author":"Shen","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.exppara.2014.08.008_b0115","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1101\/gr.149200","article-title":"A genetic linkage map of the apicomplexan protozoan parasite Eimeria tenella","volume":"10","author":"Shirley","year":"2000","journal-title":"Genome Res."},{"key":"10.1016\/j.exppara.2014.08.008_b0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0014-4894(92)90162-4","article-title":"Malaria pigment","volume":"74","author":"Slater","year":"1992","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2014.08.008_b0125","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/AAC.01256-06","article-title":"Quinoline derivative MC1626, a putative GCN5 histone acetyltransferase (HAT) inhibitor, exhibits HAT-independent activity against Toxoplasma gondii","volume":"51","author":"Smith","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2014.08.008_b0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Solomon","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exppara.2014.08.008_b0135","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/j.bmc.2009.08.068","article-title":"Hybrid pharmacophore design and synthesis of isatin\u2013benzothiazole analogs for their anti-breast cancer activity","volume":"17","author":"Solomon","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exppara.2014.08.008_b0140","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bmc.2010.01.001","article-title":"Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach","volume":"18","author":"Solomon","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exppara.2014.08.008_b0145","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.ejmech.2010.05.046","article-title":"Design and synthesis of chloroquine analogs with anti-breast cancer property","volume":"45","author":"Solomon","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2014.08.008_b0150","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.bmcl.2005.03.048","article-title":"Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity","volume":"15","author":"Ten\u00f3rio","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.exppara.2014.08.008_b0155","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1286-4579(02)01629-5","article-title":"Cryptosporidiosis: biology, pathogenesis and disease","volume":"4","author":"Tzipori","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.exppara.2014.08.008_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/984568","article-title":"Update on babesiosis","volume":"2009","author":"Vannier","year":"2009","journal-title":"Interdiscip. Perspect. Infect. Dis."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489414001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489414001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:04:50Z","timestamp":1746335090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489414001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":33,"alternative-id":["S0014489414001982"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2014.08.008","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}